Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling - PubMed (original) (raw)

. 1988 Jun 10;240(4858):1546-8.

doi: 10.1126/science.3259727.

Affiliations

• PMID: 3259727
• DOI: 10.1126/science.3259727

Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling

H Vlassara et al. Science. 1988.

Abstract

Proteins undergo a series of nonenzymatic reactions with glucose over time to form advanced glycosylation end products (AGEs). Macrophages have a receptor that recognizes the AGE moiety and mediates the uptake and degradation of AGE proteins. This removal process is associated with the production and secretion of cachectin (tumor necrosis factor) and interleukin-1, two cytokines with diverse and seemingly paradoxical biological activities. The localized release and action of these cytokines could account for the coordinated removal and replacement of senescent extracellular matrix components in normal tissue homeostasis.

PubMed Disclaimer

Similar articles

• Macrophage/monocyte receptor for nonenzymatically glycosylated protein is upregulated by cachectin/tumor necrosis factor.
  Vlassara H, Moldawer L, Chan B. Vlassara H, et al. J Clin Invest. 1989 Dec;84(6):1813-20. doi: 10.1172/JCI114366. J Clin Invest. 1989. PMID: 2556447 Free PMC article.
• Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins.
  Kirstein M, Aston C, Hintz R, Vlassara H. Kirstein M, et al. J Clin Invest. 1992 Aug;90(2):439-46. doi: 10.1172/JCI115879. J Clin Invest. 1992. PMID: 1322940 Free PMC article.
• Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes.
  Burchett SK, Weaver WM, Westall JA, Larsen A, Kronheim S, Wilson CB. Burchett SK, et al. J Immunol. 1988 May 15;140(10):3473-81. J Immunol. 1988. PMID: 3258884
• Chronic diabetic complications and tissue glycosylation. Relevant concern for diabetes-prone black population.
  Vlassara H. Vlassara H. Diabetes Care. 1990 Nov;13(11):1180-5. doi: 10.2337/diacare.13.11.1180. Diabetes Care. 1990. PMID: 2261839 Review.

Cited by

• Neuroendocrine-immune aspects of accelerated aging in rheumatoid arthritis.
  Härle P, Straub RH. Härle P, et al. Curr Rheumatol Rep. 2005 Oct;7(5):389-94. doi: 10.1007/s11926-005-0027-6. Curr Rheumatol Rep. 2005. PMID: 16174490 Review.
• Advanced glycation endproducts and osteoarthritis.
  Saudek DM, Kay J. Saudek DM, et al. Curr Rheumatol Rep. 2003 Feb;5(1):33-40. doi: 10.1007/s11926-003-0081-x. Curr Rheumatol Rep. 2003. PMID: 12590883 Review.
• The Vasculature in Prediabetes.
  Wasserman DH, Wang TJ, Brown NJ. Wasserman DH, et al. Circ Res. 2018 Apr 13;122(8):1135-1150. doi: 10.1161/CIRCRESAHA.118.311912. Circ Res. 2018. PMID: 29650631 Free PMC article. Review.
• AGE-RAGE Stress, Stressors, and Antistressors in Health and Disease.
  Prasad K, Mishra M. Prasad K, et al. Int J Angiol. 2018 Mar;27(1):1-12. doi: 10.1055/s-0037-1613678. Epub 2017 Dec 28. Int J Angiol. 2018. PMID: 29483760 Free PMC article. Review.
• Novel metabolic biomarkers of cardiovascular disease.
  Jensen MK, Bertoia ML, Cahill LE, Agarwal I, Rimm EB, Mukamal KJ. Jensen MK, et al. Nat Rev Endocrinol. 2014 Nov;10(11):659-72. doi: 10.1038/nrendo.2014.155. Epub 2014 Sep 2. Nat Rev Endocrinol. 2014. PMID: 25178732 Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon

• Other Literature Sources

  • The Lens - Patent Citations Database